The global Hematopoietic Stem Cells Transplantation market size was valued at USD 2487.2 million in 2022 and is forecast to a readjusted size of USD 3607.2 million by 2029 with a CAGR of 5.5% during review period.
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.
This report is a detailed and comprehensive analysis for global Hematopoietic Stem Cells Transplantation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hematopoietic Stem Cells Transplantation market size and forecasts, in consumption value ($ Million), 2018-2029
Global Hematopoietic Stem Cells Transplantation market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Hematopoietic Stem Cells Transplantation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Hematopoietic Stem Cells Transplantation market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hematopoietic Stem Cells Transplantation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hematopoietic Stem Cells Transplantation market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis
Stem Cells Storage
Stem Cells Consumables
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Strengths
- Increasing demand for stem cell-based therapies driven by advancements in medical technology and growing incidence of hematologic disorders.
- Significant growth in global healthcare infrastructure and rising awareness about the potential of hematopoietic stem cell therapies.
Weaknesses
- High cost and complexity of stem cell transplantation procedures, limiting accessibility for a wider population.
- Regulatory challenges and long approval timelines for new therapies may slow market growth.
Opportunities
- Rising investment in research and development for alternative stem cell therapies and improved transplantation techniques.
- Growing healthcare expenditure in emerging markets, providing new avenues for market expansion.
Threats
- Ethical concerns and regulatory scrutiny regarding stem cell sourcing and usage could impede market progression.
- Competition from other therapeutic modalities, such as gene therapy, could reduce the dominance of hematopoietic stem cell transplants.
Political
- Government policies and healthcare reforms supporting stem cell research and regenerative medicine can drive market growth.
- Regulatory frameworks regarding stem cell sourcing and transplantations may vary by region, creating challenges in market entry.
Economic
- Rising healthcare costs and the expensive nature of stem cell transplants may limit accessibility, especially in lower-income countries.
- Increased private and public investments in stem cell research could foster innovation and reduce treatment costs over time.
Social
- Growing awareness and acceptance of stem cell therapies among patients and healthcare providers can enhance market demand.
- Ethical concerns related to stem cell usage may influence public opinion and societal acceptance.
Technological
- Advancements in genetic engineering, cryopreservation, and transplantation techniques can improve treatment outcomes and market prospects.
- Development of minimally invasive procedures and personalized therapies could reduce costs and improve patient outcomes.
Environmental
- Sustainability concerns related to the sourcing of stem cells, particularly from human embryos, may impact the market.
- Environmental regulations on waste management from stem cell research facilities may pose operational challenges.
Legal
- Stringent regulations regarding the ethical use of stem cells may restrict market expansion in certain regions.
- Intellectual property issues, such as patent disputes over stem cell technologies, could affect market dynamics and competition.
Suppliers
- Stem cell banks and research institutions that provide the raw materials (e.g., stem cells) for transplantation.
- Pharmaceutical and biotech companies involved in developing and manufacturing supportive drugs and transplantation technologies.
Inputs
- Hematopoietic stem cells from bone marrow, peripheral blood, or umbilical cord blood.
- Advanced medical equipment, including cryopreservation systems and cell processing technologies.
Process
- Stem cells are harvested, processed, and preserved, followed by the transplantation into patients with hematologic diseases.
- Ongoing research and clinical trials are conducted to improve transplantation success rates and patient outcomes.
Outputs
- Successful stem cell transplants resulting in hematologic disease remission or cure.
- Data on treatment efficacy, safety profiles, and long-term patient survival rates.
Customers
- Hospitals, cancer treatment centers, and healthcare providers offering hematopoietic stem cell transplants.
- Patients suffering from hematologic conditions such as leukemia, lymphoma, or sickle cell anemia.
Threat of New Entrants
- High barriers to entry due to the complexity and cost of stem cell research and transplantation procedures.
- Regulatory hurdles and the need for specialized expertise limit new competitors from easily entering the market.
Bargaining Power of Suppliers
- Limited suppliers for high-quality hematopoietic stem cells and related research materials increase supplier power.
- Strong dependency on biotech firms for the development of supportive therapies and technologies.
Bargaining Power of Buyers
- Patients have limited bargaining power due to the highly specialized and life-saving nature of stem cell transplants.
- Increasing awareness and availability of alternative treatments may give patients more choices, thus increasing bargaining power.
Threat of Substitutes
- Emergence of alternative therapies, such as gene therapy and immunotherapies, poses a potential threat to stem cell transplantation.
- Continuous advancements in cell-based therapies may reduce reliance on traditional stem cell transplantation methods.
Industry Rivalry
- Intense competition among established pharmaceutical and biotech companies in the development of stem cell therapies.
- The growing number of research institutions and healthcare providers competing for market share can increase rivalry.
Raw Materials
- Hematopoietic stem cells are sourced from bone marrow, peripheral blood, or umbilical cord blood, requiring high-quality cell banks and medical facilities.
- There is a need for specialized cryopreservation equipment and storage systems to ensure the viability of stem cells.
Technology and Innovation
- Continuous advancements in gene editing, tissue engineering, and stem cell isolation techniques are essential for improving transplantation outcomes.
- Development of next-generation cell-processing technologies, such as automated platforms for stem cell expansion, can reduce processing time and costs.
Research and Development
- Ongoing clinical trials and research collaborations between academia, biotech companies, and hospitals drive innovations in stem cell transplantation methods.
- Investment in R&D is necessary for overcoming challenges related to graft rejection, immune compatibility, and long-term patient survival.
Regulatory Environment
- Stringent regulations governing stem cell sourcing, ethical considerations, and clinical trial approvals shape the upstream supply chain.
- Regulatory frameworks for gene therapies, which are often used in conjunction with stem cell transplants, influence market development and investment strategies.
Processing and Treatment
- Stem cells undergo processing in specialized laboratories, including purification, expansion, and sometimes genetic modification, before transplantation.
- The transplantation process involves medical centers with high expertise in hematology, oncology, and immunology, ensuring the proper match and minimal rejection.
Supply Chain and Logistics
- Efficient logistics and transportation systems are critical for maintaining the integrity and viability of stem cells during transfer from banks to hospitals.
- Cold chain logistics play a significant role in preserving stem cells, requiring robust infrastructure and adherence to stringent temperature control protocols.
Clinical Trials and Approval
- Clinical trials and research studies play a crucial role in refining stem cell transplantation techniques and ensuring safety and efficacy.
- Obtaining regulatory approval for new stem cell therapies involves navigating complex trial phases, which may delay market entry for innovative treatments.
End-User Adoption
- Hospitals and specialized treatment centers are the primary end-users, focusing on hematologic malignancies and genetic blood disorders.
- Growing patient awareness and acceptance of stem cell therapies, especially among those with life-threatening conditions, is increasing demand.
Patient Outcomes and Monitoring
- Post-transplant care and long-term monitoring of patients for complications like graft-versus-host disease (GVHD) or relapse are essential for treatment success.
- Advances in personalized medicine and biomarkers for transplant rejection are enhancing patient outcomes and driving further adoption of stem cell therapies.
Insurance and Healthcare Systems
- Coverage for stem cell transplantation varies by region and insurance policy, impacting patient access and market penetration.
- Expanding healthcare insurance coverage for stem cell treatments and therapies could lead to broader patient access and market growth.
Chapter 1, to describe Hematopoietic Stem Cells Transplantation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hematopoietic Stem Cells Transplantation, with revenue, gross margin and global market share of Hematopoietic Stem Cells Transplantation from 2018 to 2023.
Chapter 3, the Hematopoietic Stem Cells Transplantation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hematopoietic Stem Cells Transplantation market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Hematopoietic Stem Cells Transplantation.
Chapter 13, to describe Hematopoietic Stem Cells Transplantation research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Hematopoietic Stem Cells Transplantation
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hematopoietic Stem Cells Transplantation by Type
1.3.1 Overview: Global Hematopoietic Stem Cells Transplantation Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Type in 2022
1.3.3 Stem Cells Storage
1.3.4 Stem Cells Consumables
1.4 Global Hematopoietic Stem Cells Transplantation Market by Application
1.4.1 Overview: Global Hematopoietic Stem Cells Transplantation Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Leukemia
1.4.3 Lymphoproliferative Disorders
1.4.4 Solid Tumors
1.4.5 Non-Malignant Disorders
1.5 Global Hematopoietic Stem Cells Transplantation Market Size & Forecast
1.6 Global Hematopoietic Stem Cells Transplantation Market Size and Forecast by Region
1.6.1 Global Hematopoietic Stem Cells Transplantation Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Hematopoietic Stem Cells Transplantation Market Size by Region, (2018-2029)
1.6.3 North America Hematopoietic Stem Cells Transplantation Market Size and Prospect (2018-2029)
1.6.4 Europe Hematopoietic Stem Cells Transplantation Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size and Prospect (2018-2029)
1.6.6 South America Hematopoietic Stem Cells Transplantation Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Hematopoietic Stem Cells Transplantation Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 CBR Systems
2.1.1 CBR Systems Details
2.1.2 CBR Systems Major Business
2.1.3 CBR Systems Hematopoietic Stem Cells Transplantation Product and Solutions
2.1.4 CBR Systems Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CBR Systems Recent Developments and Future Plans
2.2 China Cord Blood Corporation
2.2.1 China Cord Blood Corporation Details
2.2.2 China Cord Blood Corporation Major Business
2.2.3 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product and Solutions
2.2.4 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 China Cord Blood Corporation Recent Developments and Future Plans
2.3 ViaCord
2.3.1 ViaCord Details
2.3.2 ViaCord Major Business
2.3.3 ViaCord Hematopoietic Stem Cells Transplantation Product and Solutions
2.3.4 ViaCord Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ViaCord Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product and Solutions
2.4.4 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 STEMCELL Technologies
2.5.1 STEMCELL Technologies Details
2.5.2 STEMCELL Technologies Major Business
2.5.3 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product and Solutions
2.5.4 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 STEMCELL Technologies Recent Developments and Future Plans
2.6 Vcanbio
2.6.1 Vcanbio Details
2.6.2 Vcanbio Major Business
2.6.3 Vcanbio Hematopoietic Stem Cells Transplantation Product and Solutions
2.6.4 Vcanbio Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Vcanbio Recent Developments and Future Plans
2.7 Merck Millipore
2.7.1 Merck Millipore Details
2.7.2 Merck Millipore Major Business
2.7.3 Merck Millipore Hematopoietic Stem Cells Transplantation Product and Solutions
2.7.4 Merck Millipore Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Millipore Recent Developments and Future Plans
2.8 Lonza Group
2.8.1 Lonza Group Details
2.8.2 Lonza Group Major Business
2.8.3 Lonza Group Hematopoietic Stem Cells Transplantation Product and Solutions
2.8.4 Lonza Group Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Lonza Group Recent Developments and Future Plans
2.9 CellGenix Technologie Transfer
2.9.1 CellGenix Technologie Transfer Details
2.9.2 CellGenix Technologie Transfer Major Business
2.9.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product and Solutions
2.9.4 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 CellGenix Technologie Transfer Recent Developments and Future Plans
2.10 ThermoGenesis
2.10.1 ThermoGenesis Details
2.10.2 ThermoGenesis Major Business
2.10.3 ThermoGenesis Hematopoietic Stem Cells Transplantation Product and Solutions
2.10.4 ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ThermoGenesis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hematopoietic Stem Cells Transplantation Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Hematopoietic Stem Cells Transplantation by Company Revenue
3.2.2 Top 3 Hematopoietic Stem Cells Transplantation Players Market Share in 2022
3.2.3 Top 6 Hematopoietic Stem Cells Transplantation Players Market Share in 2022
3.3 Hematopoietic Stem Cells Transplantation Market: Overall Company Footprint Analysis
3.3.1 Hematopoietic Stem Cells Transplantation Market: Region Footprint
3.3.2 Hematopoietic Stem Cells Transplantation Market: Company Product Type Footprint
3.3.3 Hematopoietic Stem Cells Transplantation Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Hematopoietic Stem Cells Transplantation Consumption Value and Market Share by Type (2018-2023)
4.2 Global Hematopoietic Stem Cells Transplantation Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Application (2018-2023)
5.2 Global Hematopoietic Stem Cells Transplantation Market Forecast by Application (2024-2029)
6 North America
6.1 North America Hematopoietic Stem Cells Transplantation Consumption Value by Type (2018-2029)
6.2 North America Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2029)
6.3 North America Hematopoietic Stem Cells Transplantation Market Size by Country
6.3.1 North America Hematopoietic Stem Cells Transplantation Consumption Value by Country (2018-2029)
6.3.2 United States Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
6.3.3 Canada Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
6.3.4 Mexico Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Hematopoietic Stem Cells Transplantation Consumption Value by Type (2018-2029)
7.2 Europe Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2029)
7.3 Europe Hematopoietic Stem Cells Transplantation Market Size by Country
7.3.1 Europe Hematopoietic Stem Cells Transplantation Consumption Value by Country (2018-2029)
7.3.2 Germany Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
7.3.3 France Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
7.3.5 Russia Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
7.3.6 Italy Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size by Region
8.3.1 Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Region (2018-2029)
8.3.2 China Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
8.3.3 Japan Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
8.3.4 South Korea Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
8.3.5 India Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
8.3.7 Australia Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
9 South America
9.1 South America Hematopoietic Stem Cells Transplantation Consumption Value by Type (2018-2029)
9.2 South America Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2029)
9.3 South America Hematopoietic Stem Cells Transplantation Market Size by Country
9.3.1 South America Hematopoietic Stem Cells Transplantation Consumption Value by Country (2018-2029)
9.3.2 Brazil Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
9.3.3 Argentina Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country
10.3.1 Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Country (2018-2029)
10.3.2 Turkey Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
10.3.4 UAE Hematopoietic Stem Cells Transplantation Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Hematopoietic Stem Cells Transplantation Market Drivers
11.2 Hematopoietic Stem Cells Transplantation Market Restraints
11.3 Hematopoietic Stem Cells Transplantation Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Hematopoietic Stem Cells Transplantation Industry Chain
12.2 Hematopoietic Stem Cells Transplantation Upstream Analysis
12.3 Hematopoietic Stem Cells Transplantation Midstream Analysis
12.4 Hematopoietic Stem Cells Transplantation Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Hematopoietic Stem Cells Transplantation Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hematopoietic Stem Cells Transplantation Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Hematopoietic Stem Cells Transplantation Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Hematopoietic Stem Cells Transplantation Consumption Value by Region (2024-2029) & (USD Million)
Table 5. CBR Systems Company Information, Head Office, and Major Competitors
Table 6. CBR Systems Major Business
Table 7. CBR Systems Hematopoietic Stem Cells Transplantation Product and Solutions
Table 8. CBR Systems Hematopoietic Stem Cells Transplantation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. CBR Systems Recent Developments and Future Plans
Table 10. China Cord Blood Corporation Company Information, Head Office, and Major Competitors
Table 11. China Cord Blood Corporation Major Business
Table 12. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product and Solutions
Table 13. China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. China Cord Blood Corporation Recent Developments and Future Plans
Table 15. ViaCord Company Information, Head Office, and Major Competitors
Table 16. ViaCord Major Business
Table 17. ViaCord Hematopoietic Stem Cells Transplantation Product and Solutions
Table 18. ViaCord Hematopoietic Stem Cells Transplantation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. ViaCord Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product and Solutions
Table 23. Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. STEMCELL Technologies Company Information, Head Office, and Major Competitors
Table 26. STEMCELL Technologies Major Business
Table 27. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product and Solutions
Table 28. STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. STEMCELL Technologies Recent Developments and Future Plans
Table 30. Vcanbio Company Information, Head Office, and Major Competitors
Table 31. Vcanbio Major Business
Table 32. Vcanbio Hematopoietic Stem Cells Transplantation Product and Solutions
Table 33. Vcanbio Hematopoietic Stem Cells Transplantation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Vcanbio Recent Developments and Future Plans
Table 35. Merck Millipore Company Information, Head Office, and Major Competitors
Table 36. Merck Millipore Major Business
Table 37. Merck Millipore Hematopoietic Stem Cells Transplantation Product and Solutions
Table 38. Merck Millipore Hematopoietic Stem Cells Transplantation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Merck Millipore Recent Developments and Future Plans
Table 40. Lonza Group Company Information, Head Office, and Major Competitors
Table 41. Lonza Group Major Business
Table 42. Lonza Group Hematopoietic Stem Cells Transplantation Product and Solutions
Table 43. Lonza Group Hematopoietic Stem Cells Transplantation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Lonza Group Recent Developments and Future Plans
Table 45. CellGenix Technologie Transfer Company Information, Head Office, and Major Competitors
Table 46. CellGenix Technologie Transfer Major Business
Table 47. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product and Solutions
Table 48. CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. CellGenix Technologie Transfer Recent Developments and Future Plans
Table 50. ThermoGenesis Company Information, Head Office, and Major Competitors
Table 51. ThermoGenesis Major Business
Table 52. ThermoGenesis Hematopoietic Stem Cells Transplantation Product and Solutions
Table 53. ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. ThermoGenesis Recent Developments and Future Plans
Table 55. Global Hematopoietic Stem Cells Transplantation Revenue (USD Million) by Players (2018-2023)
Table 56. Global Hematopoietic Stem Cells Transplantation Revenue Share by Players (2018-2023)
Table 57. Breakdown of Hematopoietic Stem Cells Transplantation by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Hematopoietic Stem Cells Transplantation, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Hematopoietic Stem Cells Transplantation Players
Table 60. Hematopoietic Stem Cells Transplantation Market: Company Product Type Footprint
Table 61. Hematopoietic Stem Cells Transplantation Market: Company Product Application Footprint
Table 62. Hematopoietic Stem Cells Transplantation New Market Entrants and Barriers to Market Entry
Table 63. Hematopoietic Stem Cells Transplantation Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Hematopoietic Stem Cells Transplantation Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Hematopoietic Stem Cells Transplantation Consumption Value Share by Type (2018-2023)
Table 66. Global Hematopoietic Stem Cells Transplantation Consumption Value Forecast by Type (2024-2029)
Table 67. Global Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2023)
Table 68. Global Hematopoietic Stem Cells Transplantation Consumption Value Forecast by Application (2024-2029)
Table 69. North America Hematopoietic Stem Cells Transplantation Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Hematopoietic Stem Cells Transplantation Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Hematopoietic Stem Cells Transplantation Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Hematopoietic Stem Cells Transplantation Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Hematopoietic Stem Cells Transplantation Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Hematopoietic Stem Cells Transplantation Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Hematopoietic Stem Cells Transplantation Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Hematopoietic Stem Cells Transplantation Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Hematopoietic Stem Cells Transplantation Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Hematopoietic Stem Cells Transplantation Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Hematopoietic Stem Cells Transplantation Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Hematopoietic Stem Cells Transplantation Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Hematopoietic Stem Cells Transplantation Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Hematopoietic Stem Cells Transplantation Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Hematopoietic Stem Cells Transplantation Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Hematopoietic Stem Cells Transplantation Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Hematopoietic Stem Cells Transplantation Raw Material
Table 100. Key Suppliers of Hematopoietic Stem Cells Transplantation Raw Materials
List of Figures
Figure 1. Hematopoietic Stem Cells Transplantation Picture
Figure 2. Global Hematopoietic Stem Cells Transplantation Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Type in 2022
Figure 4. Stem Cells Storage
Figure 5. Stem Cells Consumables
Figure 6. Global Hematopoietic Stem Cells Transplantation Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Application in 2022
Figure 8. Leukemia Picture
Figure 9. Lymphoproliferative Disorders Picture
Figure 10. Solid Tumors Picture
Figure 11. Non-Malignant Disorders Picture
Figure 12. Global Hematopoietic Stem Cells Transplantation Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Hematopoietic Stem Cells Transplantation Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Hematopoietic Stem Cells Transplantation Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Region in 2022
Figure 17. North America Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Hematopoietic Stem Cells Transplantation Revenue Share by Players in 2022
Figure 23. Hematopoietic Stem Cells Transplantation Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Hematopoietic Stem Cells Transplantation Market Share in 2022
Figure 25. Global Top 6 Players Hematopoietic Stem Cells Transplantation Market Share in 2022
Figure 26. Global Hematopoietic Stem Cells Transplantation Consumption Value Share by Type (2018-2023)
Figure 27. Global Hematopoietic Stem Cells Transplantation Market Share Forecast by Type (2024-2029)
Figure 28. Global Hematopoietic Stem Cells Transplantation Consumption Value Share by Application (2018-2023)
Figure 29. Global Hematopoietic Stem Cells Transplantation Market Share Forecast by Application (2024-2029)
Figure 30. North America Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 40. France Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Region (2018-2029)
Figure 47. China Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 50. India Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Hematopoietic Stem Cells Transplantation Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Hematopoietic Stem Cells Transplantation Consumption Value (2018-2029) & (USD Million)
Figure 64. Hematopoietic Stem Cells Transplantation Market Drivers
Figure 65. Hematopoietic Stem Cells Transplantation Market Restraints
Figure 66. Hematopoietic Stem Cells Transplantation Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Hematopoietic Stem Cells Transplantation in 2022
Figure 69. Manufacturing Process Analysis of Hematopoietic Stem Cells Transplantation
Figure 70. Hematopoietic Stem Cells Transplantation Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
